Kliniq is a boutique digital platform for clinical trial support.
Kliniq eConsent is a patient-centric tool to alleviate the in-person consenting process. It provides simple and efficient solutions for remote consenting of voluntary participating patients in clinical trials. Kliniq eConsent allows an easy connection between the sites and patients.
Kliniq eConsent is available to CROs and sites to assist and improve patient enrollment in clinical trials.
Adelina Paunescu, CEO & Co-founder
Adelina Paunescu is the co-founder and CEO of Kliniq, bringing more than 20 years in management and execution experience of clinical trials in healthcare industry. Her expertise comes from a long history leading cardiac devices clinical trials in a variety of companies such as Abiomed, Heartware, Transmedics as well as other therapeutics areas including Oncology, Hematology. Adelina founded ACMP Clinical and Regulatory Consulting LLC, a consulting firm who advised companies on a wide range of clinical and regulatory matters in different therapeutic areas. Adelina holds a PhD in Biophysics from University of Illinois at Urbana Champaign and MS in Physics from University of Bucharest.
Dan Grigorovici, CTO & Co-founder
Dan is a 17 years ad tech and data product veteran who has led product innovation, big data analytics, and targeting for networks, DSPs, SSPs, and DMPs with equal experience in display, mobile, video, and DOOH. A "glass half empty" type, he is a big advocate of the Lean product process. He founded (and later sold to Lotame) one of the first cross-device and mobile DMPs, AdMobius. Part of the former Quattro Wireless executive team, he continued to lead Analytics, Targeting, and Optimization for iAd after its acquisition by Apple. Prior to Quattro, he led the Analytics, Data, and Targeting divisions at Rapp/Omnicom, Carat, and Tacoda. Dan received his B.A. in Philosophy and M.A. in Political Science from University of Bucharest and his Ph.D (ABD) in Communication from Penn State University.
Jerika Acosta, COO
Jerika Acosta joins Kliniq with over 17 years of industry leadership and management experience in Phase I-IV pharmaceutical and device clinical trials. She has worked in CRO, pharma, and academic environments, including operational oversight of multi-therapeutic global programs leading to successful regulatory submissions and product launches for multiple leading organizations. She has managed multi-compound portfolios inclusive of adult and pediatric trials in large programs. Jerika’s background includes Clinical Development, Program Management, Strategic Planning, Risk Management, and Process Excellence across multiple therapeutic areas such as Oncology, Infectious Diseases, Neurology, and others. Jerika received her B.S. in Pharmacology from Mario Ernest (Rutgers School of Pharmacy) and continued her studies to obtain a PharmD.